Research: Virus delays progression of pediatric tumors

02/17/2008 | Washington Post, The

A new study revealed that a laboratory-engineered virus known as rQT3 delayed the development of neuroblastoma and peripheral nerve sheath tumors without damaging healthy tissues and prolonged the life span of diseased mice. Researchers created the viral therapy by equipping the oncolytic herpes simplex virus with a gene that inhibits enzymes responsible for the growth of certain tumors.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA